Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Y-4 to Treat the Postherpetic Neuralgia — Stella

Home/Postherpetic Neuralgia/Y-4 to Treat the Postherpetic Neuralgia

View on ClinicalTrials.gov

Recruiting

Back to Postherpetic Neuralgia trials

Y-4 to Treat the Postherpetic Neuralgia

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

China

Hospital for Skin Diseases, Chinese Academy of Medical Sciences, Nanjing, Jiangsu

Key details

Phase

Safety & dosing

Sponsor

Neurodawn Pharmaceutical Co., Ltd.

Enrollment target

~160 participants

Started

February 2026

Primary completion

July 2026

Age range

18 Years and older

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.